Showing results (81-90 of 174) with videos related to
Sort By:
Pageof 18
Il Giornale Di Chirurgia|March 1, 1994
[Papillomatous lesions of the biliary tract]G Lucandri, M Mungo, E Meloni, et al.Acta Bio-Medica De L'Ateneo Parmense : Organo Della Societa Di Medicina E Scienze Naturali Di Parma|June 27, 2001
[Prevalence and distribution of congenital cardiopathy at birth and in pregnancy termination: impact of prenatal diagnosis in 4 years of experience]A Vimercati, P Greco, F Di Fazio, et al.Prostaglandins|June 1, 1980
Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteriesM F Gimeno, L Sterin-Borda, E S Borda, et al.Thrombosis Research|September 7, 2005
Endogenous or exogenous coagulation factor level and the response to activated protein CLaura C Gennari, Alicia N Blanco, Maria P Domínguez, et al.Bone|May 12, 2012
Circulating sclerostin is elevated in short-term and reduced in long-term SCIRicardo A Battaglino, Supreetha Sudhakar, Antonio A Lazzari, et al.Thrombosis and Haemostasis|January 1, 1997
Enhanced response to chemotactic activation of polymorphonuclear leukocytes from patients with heart valve replacementN Maugeri, A C Kempfer, V Evangelista, et al.Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1983
The stimulatory effect of prostacyclin (PGI2) on isolated rabbit and rat aorta is probably associated to the generation of a thromboxane A2 (TXA2) "like-material"E S Borda, L Sterin-Borda, M F Gimeno, et al.American Journal of Hematology|March 8, 2000
Bleeding risk factors in chronic oral anticoagulation with acenocoumarolP Casais, A Sánchez Luceros, S Meschengieser, et al.Hematology (Amsterdam, Netherlands)|April 18, 2012
Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosisM A Lazzari, A Sanchez-Luceros, A I Woods, et al.Thrombosis Research|November 1, 1987
Intraplatelet levels of vWF:Ag and fibrinogen in myeloproliferative disordersS Meschengieser, A Blanco, A Woods, et al.Pageof 18